Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | Highlights from the MDS 2020 congress

Carlos Henrique Camargo • 7 Sep 2020
MDS 2020
Movement Disorders Parkinson's Disease

Carlos Henrique Camargo, MD, PhD, Federal University of Parana, Curitiba, Parana, Brazil, expresses his excitement for the MDS 2020 congress, in particular the role of genetics in movement disorders and their treatment. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Carlos Henrique Camargo

2:05
Spasticity and ataxia: lack of available treatment and the importance of rehabilitation
Carlos Henrique Camargo • 7 Sep 2020
3:22
Challenges of diagnosing and managing movement disorders in developing countries
Carlos Henrique Camargo • 7 Sep 2020

Related Videos

5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
2:51
Overlap in etiology between different FND subtypes
Mark Hallett • 15 Apr 2024
1:58
Ambroxol & other targeted therapies in Parkinson's
K Ray Chaudhuri • 21 Mar 2024
3:00
The use of precision medicine in Parkinson’s disease
K Ray Chaudhuri • 21 Mar 2024
The content of VJNeurology is intended for healthcare professionals